An updated pharmacological insight of resveratrol in the treatment of diabetic nephropathy
出版年份 2021 全文链接
标题
An updated pharmacological insight of resveratrol in the treatment of diabetic nephropathy
作者
关键词
Phytochemicals, Nephropathy, Diabetes, Resveratrol, Oxidative stress
出版物
GENE
Volume 780, Issue -, Pages 145532
出版商
Elsevier BV
发表日期
2021-02-23
DOI
10.1016/j.gene.2021.145532
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Hyperglycemic levels in early stage of diabetic nephropathy affect differentially renal expression of claudins-2 and -5 by oxidative stress
- (2021) Lorena Rosas-Martínez et al. LIFE SCIENCES
- Metabolic memory and diabetic nephropathy: Beneficial effects of natural epigenetic modifiers
- (2020) Kriti Kushwaha et al. BIOCHIMIE
- Sodium‐glucose co‐transporters and diabetic nephropathy: Is there a link with toll‐like receptors?
- (2020) Zahra Ashrafi Jigheh et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- Resveratrol prevents diabetic nephropathy by reducing chronic inflammation and improving the blood glucose memory effect in non-obese diabetic mice
- (2020) Yuxin Xian et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- Folic acid and melatonin mitigate diabetic nephropathy in rats via inhibition of oxidative stress
- (2020) Hossam Ebaid et al. Nutrition & Metabolism
- Efficacy and Safety of Resveratrol in Type 1 Diabetes Patients: A Two-Month Preliminary Exploratory Trial
- (2020) Ali Movahed et al. Nutrients
- Biochemical, serological, and genetic aspects related to gene HLA‐DQB1 and its association with type 1 diabetes mellitus (T1DM)
- (2020) Gur Charn Singh et al. Molecular Genetics & Genomic Medicine
- A review on the potential of Resveratrol in prevention and therapy of diabetes and diabetic complications
- (2020) Dan-Dan Huang et al. BIOMEDICINE & PHARMACOTHERAPY
- SGLT2 Inhibitor Empagliflozin and DPP4 Inhibitor Linagliptin Reactivate Glomerular Autophagy in db/db Mice, a Model of Type 2 Diabetes
- (2020) Anton I. Korbut et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Potential Adverse Effects of Resveratrol: A Literature Review
- (2020) Abdullah Shaito et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Molecular Mechanisms Linking Oxidative Stress and Diabetes Mellitus
- (2020) Habib Yaribeygi et al. Oxidative Medicine and Cellular Longevity
- Protective factors as biomarkers and targets for prevention and treatment of diabetic nephropathy: From current human evidence to future possibilities
- (2020) Natalia Nowak Journal of Diabetes Investigation
- Sirt1 inhibits renal tubular cell epithelial–mesenchymal transition through YY1 deacetylation in diabetic nephropathy
- (2020) Lei Du et al. ACTA PHARMACOLOGICA SINICA
- Curcumin derivatives for Type 2 Diabetes management and prevention of complications
- (2020) Sara Oliveira et al. ARCHIVES OF PHARMACAL RESEARCH
- A Role for GLP-1 in Treating Hyperphagia and Obesity
- (2020) Harvey J Grill ENDOCRINOLOGY
- Resveratrol – A comprehensive review of recent advances in anticancer drug design and development
- (2020) Reza Ahmadi et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Lysosomal dysfunction–induced autophagic stress in diabetic kidney disease
- (2020) Hui Juan Zheng et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- LncRNAs and circular RNAs as endothelial cell messengers in hypertension: mechanism insights and therapeutic potential
- (2020) Ji-Ru Zhang et al. MOLECULAR BIOLOGY REPORTS
- Resveratrol: Evidence for Its Nephroprotective Effect in Diabetic Nephropathy
- (2020) Vemana Gowd et al. Advances in Nutrition
- Role of Sirtuins in Modulating Neurodegeneration of the Enteric Nervous System and Central Nervous System
- (2020) Pavithra Chandramowlishwaran et al. Frontiers in Neuroscience
- A G-quadruplex nanoswitch in the SGK1 promoter regulates isoform expression by K+/Na+ balance and resveratrol binding
- (2020) Mengjie Chen et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Sirtuins and Type 2 Diabetes: Role in Inflammation, Oxidative Stress, and Mitochondrial Function
- (2019) Munehiro Kitada et al. Frontiers in Endocrinology
- Role of sirtuin-1 in diabetic nephropathy
- (2019) Wanning Wang et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Novel tubular–glomerular interplay in diabetic kidney disease mediated by sirtuin 1, nicotinamide mononucleotide, and nicotinamide adenine dinucleotide Oshima Award Address 2017
- (2019) Kazuhiro Hasegawa Clinical and Experimental Nephrology
- AMPK signalling: Implications for podocyte biology in diabetic nephropathy
- (2019) Maria Szrejder et al. BIOLOGY OF THE CELL
- Characterization of Glycolytic Enzymes and Pyruvate Kinase M2 in Type 1 and 2 Diabetic Nephropathy
- (2019) Daniel Gordin et al. DIABETES CARE
- Ramipril and resveratrol co‐treatment attenuates RhoA/ROCK pathway‐regulated early‐stage diabetic nephropathy‐associated glomerulosclerosis in streptozotocin‐induced diabetic rats
- (2019) Xiang Peng et al. ENVIRONMENTAL TOXICOLOGY
- Vaccarin ameliorates insulin resistance and steatosis by activating the AMPK signaling pathway
- (2019) Yueyue Lei et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Mechanisms of Adiponectin Action: Implication of Adiponectin Receptor Agonism in Diabetic Kidney Disease
- (2019) Yaeni Kim et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Role of Nampt-Sirt6 Axis in Renal Proximal Tubules in Extracellular Matrix Deposition in Diabetic Nephropathy
- (2019) Hirokazu Muraoka et al. Cell Reports
- Pharmacological Basis and New Insights of Resveratrol Action in the Cardiovascular System
- (2019) Chak Kwong Cheng et al. BRITISH JOURNAL OF PHARMACOLOGY
- Long noncoding RNA: an emerging player in diabetes and diabetic kidney disease
- (2019) Jia Guo et al. CLINICAL SCIENCE
- Health Benefits of Resveratrol in Kidney Disease: Evidence from In Vitro and In Vivo Studies
- (2019) Danja J. Den Hartogh et al. Nutrients
- Screening Analysis of Sirtuins Family Expression on Anti-Inflammation of Resveratrol in Endothelial Cells
- (2019) Huizhen Yu et al. MEDICAL SCIENCE MONITOR
- Molecular Interactions Between Reactive Oxygen Species and Autophagy in Kidney Disease
- (2019) Gur P. Kaushal et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Increased apolipoprotein C3 drives cardiovascular risk in type 1 diabetes
- (2019) Jenny E. Kanter et al. JOURNAL OF CLINICAL INVESTIGATION
- mTORC1-to-AMPK switching underlies β cell metabolic plasticity during maturation and diabetes
- (2019) Rami Jaafar et al. JOURNAL OF CLINICAL INVESTIGATION
- Hydrogen Sulfide: Recent Progression and Perspectives for the Treatment of Diabetic Nephropathy
- (2019) Sun et al. MOLECULES
- Stimulation of Na+/K+-ATPase with an Antibody against Its 4th Extracellular Region Attenuates Angiotensin II-Induced H9c2 Cardiomyocyte Hypertrophy via an AMPK/SIRT3/PPARγ Signaling Pathway
- (2019) Siping Xiong et al. Oxidative Medicine and Cellular Longevity
- The Effect of Resveratrol Supplementation on Cardio‐Metabolic Risk Factors in Patients with Type 2 Diabetes: A Randomized, Double‐Blind Controlled Trial
- (2019) Shima Abdollahi et al. PHYTOTHERAPY RESEARCH
- microRNA Crosstalk Influences Epithelial-to-Mesenchymal, Endothelial-to-Mesenchymal, and Macrophage-to-Mesenchymal Transitions in the Kidney
- (2019) Swayam Prakash Srivastava et al. Frontiers in Pharmacology
- Tubular NOX4 expression decreases in chronic kidney disease but does not modify fibrosis evolution
- (2019) Renuga Devi Rajaram et al. Redox Biology
- A novel compound AB38b attenuates oxidative stress and ECM protein accumulation in kidneys of diabetic mice through modulation of Keap1/Nrf2 signaling
- (2019) Lei Du et al. ACTA PHARMACOLOGICA SINICA
- Lysosome restoration to activate podocyte autophagy: a new therapeutic strategy for diabetic kidney disease
- (2019) Wei Jing Liu et al. Cell Death & Disease
- Effects of Resveratrol in Goto-Kakizaki Rat, a Model of Type 2 Diabetes
- (2019) Katarzyna Szkudelska et al. Nutrients
- Chinese Herbal Medicine in Ameliorating Diabetic Kidney Disease via Activating Autophagy
- (2019) Yuyang Wang et al. Journal of Diabetes Research
- Resveratrol ameliorates metabolic disorders and insulin resistance in high-fat diet-fed mice
- (2019) Longlong Gong et al. LIFE SCIENCES
- The effects of resveratrol on markers of oxidative stress in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled clinical trial
- (2018) ShadiSadat Seyyedebrahimi et al. ACTA DIABETOLOGICA
- Modulating autophagy in cancer therapy: Advancements and challenges for cancer cell death sensitization
- (2018) Punya Bhat et al. BIOCHEMICAL PHARMACOLOGY
- Metabolism and pharmacokinetics of resveratrol and pterostilbene
- (2018) Pei Wang et al. BIOFACTORS
- Resveratrol reduces albuminuria in diabetic nephropathy: A randomized double-blind placebo-controlled clinical trial
- (2018) A. Sattarinezhad et al. DIABETES & METABOLISM
- Risk of Cardiovascular Disease and Death in Individuals With Prediabetes Defined by Different Criteria: The Whitehall II Study
- (2018) Dorte Vistisen et al. DIABETES CARE
- Mangiferin prevents diabetic nephropathy progression and protects podocyte function via autophagy in diabetic rat glomeruli
- (2018) Xiaodan Wang et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- The Adiponectin Receptor Agonist AdipoRon Ameliorates Diabetic Nephropathy in a Model of Type 2 Diabetes
- (2018) Yaeni Kim et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Sirtuins in Renal Health and Disease
- (2018) Marina Morigi et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Update of pathophysiology and management of diabetic kidney disease
- (2018) Yi-Chih Lin et al. JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION
- Advanced glycation end products in the pathogenesis of chronic kidney disease
- (2018) Naila Rabbani et al. KIDNEY INTERNATIONAL
- Adiponectin receptor agonist AdipoRon decreased ceramide, and lipotoxicity, and ameliorated diabetic nephropathy
- (2018) Sun Ryoung Choi et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Effect of resveratrol supplementation on lipid profile in subjects with dyslipidemia: A randomized double-blind placebo-controlled trial
- (2018) Luis E. Simental-Mendía et al. NUTRITION
- Resveratrol supplementation decreases blood glucose without changing the circulating CD14 + CD16 + monocytes and inflammatory cytokines in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled study
- (2018) Hadi Khodabandehloo et al. NUTRITION RESEARCH
- Trans -resveratrol mitigates type 1 diabetes-induced oxidative DNA damage and accumulation of advanced glycation end products in glomeruli and tubules of rat kidneys
- (2018) Heba Al-Hussaini et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Effect of resveratrol treatment on graft revascularization after islet transplantation in streptozotocin-induced diabetic mice
- (2018) Eun-Mi Lee et al. Islets
- Concomitant administration of resveratrol and insulin protects against diabetes mellitus type-1-induced renal damage and impaired function via an antioxidant-mediated mechanism and up-regulation of Na+/K+-ATPase
- (2018) Salah O. Bashir ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY
- Resveratrol improves ex vivo mitochondrial function but does not affect insulin sensitivity or brown adipose tissue in first degree relatives of patients with type 2 diabetes
- (2018) Marlies de Ligt et al. Molecular Metabolism
- Reactive oxygen species promote tubular injury in diabetic nephropathy: The role of the mitochondrial ros-txnip-nlrp3 biological axis
- (2018) Yachun Han et al. Redox Biology
- TXNIP mediated the oxidative stress response in glomerular mesangial cells partially through AMPK pathway
- (2018) Wenwei Xu et al. BIOMEDICINE & PHARMACOTHERAPY
- Resveratrol ameliorates podocyte damage in diabetic mice via SIRT1/PGC-1α mediated attenuation of mitochondrial oxidative stress
- (2018) Tao Zhang et al. JOURNAL OF CELLULAR PHYSIOLOGY
- DR region of Na+-K+-ATPase is a new target to protect heart against oxidative injury
- (2018) Fei Hua et al. Scientific Reports
- Polyphenols of Myrica faya inhibit key enzymes linked to type II diabetes and obesity and formation of advanced glycation end-products (in vitro): Potential role in the prevention of diabetic complications
- (2018) Vítor Spínola et al. FOOD RESEARCH INTERNATIONAL
- AMPK in microvascular complications of diabetes and the beneficial effects of AMPK activators from plants
- (2018) C.B. Shrikanth et al. PHYTOMEDICINE
- SIRT1 Is a Potential Drug Target for Treatment of Diabetic Kidney Disease
- (2018) Yifei Zhong et al. Frontiers in Endocrinology
- Urinary Proteomics for the Early Diagnosis of Diabetic Nephropathy in Taiwanese Patients
- (2018) Wen-Ling Liao et al. Journal of Clinical Medicine
- SIRT-3 Modulation by Resveratrol Improves Mitochondrial Oxidative Phosphorylation in Diabetic Heart through Deacetylation of TFAM
- (2018) Pankaj Bagul et al. Cells
- Salidroside stimulates the Sirt1/PGC-1α axis and ameliorates diabetic nephropathy in mice
- (2018) Haiyan Xue et al. PHYTOMEDICINE
- Berberine enhances the AMPK activation and autophagy and mitigates high glucose-induced apoptosis of mouse podocytes
- (2017) Yingli Jin et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Resveratrol has anti-thyroid effects both in vitro and in vivo
- (2017) Cesidio Giuliani et al. FOOD AND CHEMICAL TOXICOLOGY
- Resveratrol attenuates reproductive alterations in type 1 diabetes-induced rats
- (2017) Joana Noguères Simas et al. INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY
- Monitoring and Measuring Autophagy
- (2017) Saori R. Yoshii et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- C1q/TNF-Related Protein-9 Ameliorates Ox-LDL-Induced Endothelial Dysfunction via PGC-1α/AMPK-Mediated Antioxidant Enzyme Induction
- (2017) Haijian Sun et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Polydatin impairs mitochondria fitness and ameliorates podocyte injury by suppressing Drp1 expression
- (2017) Zheng Ni et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Proximal Tubular Cannabinoid-1 Receptor Regulates Obesity-Induced CKD
- (2017) Shiran Udi et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Protein tyrosine phosphatase 1B deficiency in podocytes mitigates hyperglycemia-induced renal injury
- (2017) Yoshihiro Ito et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Resveratrol Improves Glycemic Control in Type 2 Diabetic Obese Mice by Regulating Glucose Transporter Expression in Skeletal Muscle and Liver
- (2017) et al. MOLECULES
- Cinnamaldehyde in diabetes: A review of pharmacology, pharmacokinetics and safety
- (2017) Ruyuan Zhu et al. PHARMACOLOGICAL RESEARCH
- Autophagy blockade and lysosomal membrane permeabilization contribute to lead-induced nephrotoxicity in primary rat proximal tubular cells
- (2017) Xiang-Bin Song et al. Cell Death & Disease
- Resveratrol ameliorates diabetic nephropathy in rats through negative regulation of the p38 MAPK/TGF-β1 pathway
- (2017) Yuan Qiao et al. Experimental and Therapeutic Medicine
- Global causes of blindness and distance vision impairment 1990–2020: a systematic review and meta-analysis
- (2017) Seth R Flaxman et al. Lancet Global Health
- Antioxidant agents for delaying diabetic kidney disease progression: A systematic review and meta-analysis
- (2017) Davide Bolignano et al. PLoS One
- Resveratrol protects podocytes against apoptosis via stimulation of autophagy in a mouse model of diabetic nephropathy
- (2017) Shan-Shan Huang et al. Scientific Reports
- Effect of resveratrol and rosuvastatin on experimental diabetic nephropathy in rats
- (2016) Mohamed M.A. Hussein et al. BIOMEDICINE & PHARMACOTHERAPY
- SIRT1 activator ameliorates the renal tubular injury induced by hyperglycemia in vivo and in vitro via inhibiting apoptosis
- (2016) Xue-ling Wang et al. BIOMEDICINE & PHARMACOTHERAPY
- Resveratrol ameliorates renal injury in spontaneously hypertensive rats by inhibiting renal micro-inflammation
- (2016) H.-Y. Xue et al. BIOSCIENCE REPORTS
- Aldosterone in vascular and metabolic dysfunction
- (2016) James M. Luther CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
- Resveratrol as Add-on Therapy in Subjects With Well-Controlled Type 2 Diabetes: A Randomized Controlled Trial
- (2016) Silvie Timmers et al. DIABETES CARE
- Mir-217 promotes inflammation and fibrosis in high glucose cultured rat glomerular mesangial cells via Sirt1/HIF-1α signaling pathway
- (2016) Ying Shao et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Sirtuin 1 and 7 mediate resveratrol-induced recovery from hyper-anxiety in high-fructose-fed prediabetic rats
- (2016) B Raghunath Reddy et al. JOURNAL OF BIOSCIENCES
- GSTM1 null genotype and susceptibility to cervical cancer in the Chinese population: An updated meta-analysis
- (2016) Wei-Qi Song et al. Journal of Cancer Research and Therapeutics
- Resveratrol inhibits renal interstitial fibrosis in diabetic nephropathy by regulating AMPK/NOX4/ROS pathway
- (2016) Ting He et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Resveratrol increases AdipoR1 and AdipoR2 expression in type 2 diabetic nephropathy
- (2016) Hoon Suk Park et al. Journal of Translational Medicine
- Autophagy in acute kidney injury
- (2016) Gur P. Kaushal et al. KIDNEY INTERNATIONAL
- HRD1-Mediated IGF-1R Ubiquitination Contributes to Renal Protection of Resveratrol indb/dbMice
- (2016) Caifeng Yan et al. MOLECULAR ENDOCRINOLOGY
- Sirt1 is essential for resveratrol enhancement of hypoxia-induced autophagy in the type 2 diabetic nephropathy rat
- (2016) Liqun Ma et al. PATHOLOGY RESEARCH AND PRACTICE
- Six months of resveratrol supplementation has no measurable effect in type 2 diabetic patients. A randomized, double blind, placebo-controlled trial
- (2016) S. Bo et al. PHARMACOLOGICAL RESEARCH
- The Impact of Resveratrol Supplementation on Blood Glucose, Insulin, Insulin Resistance, Triglyceride, and Periodontal Markers in Type 2 Diabetic Patients with Chronic Periodontitis
- (2016) Ahmad Zare Javid et al. PHYTOTHERAPY RESEARCH
- Administration of resveratrol for 5 wk has no effect on glucagon-like peptide 1 secretion, gastric emptying, or glycemic control in type 2 diabetes: a randomized controlled trial
- (2015) Sony S Thazhath et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Angiotensin-converting Enzyme Inhibitor-induced Angioedema
- (2015) Shira Bezalel et al. AMERICAN JOURNAL OF MEDICINE
- Effect of resveratrol on sirtuins expression and cardiac complications in diabetes
- (2015) Pankaj K. Bagul et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Study of autophagy-related protein light chain 3 (LC3)-II expression levels in thyroid diseases
- (2015) Ning Zhang et al. BIOMEDICINE & PHARMACOTHERAPY
- Effects of Sevelamer Carbonate on Advanced Glycation End Products and Antioxidant/Pro-Oxidant Status in Patients with Diabetic Kidney Disease
- (2015) E. M. Yubero-Serrano et al. Clinical Journal of the American Society of Nephrology
- Impaired Podocyte Autophagy Exacerbates Proteinuria in Diabetic Nephropathy
- (2015) Atsuko Tagawa et al. DIABETES
- Stability and solubility of trans-resveratrol are strongly influenced by pH and temperature
- (2015) Špela Zupančič et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- The Role of Autophagy in Lupus Nephritis
- (2015) Linlin Wang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Polydatin promotes Nrf2-ARE anti-oxidative pathway through activating Sirt1 to resist AGEs-induced upregulation of fibronetin and transforming growth factor-β1 in rat glomerular messangial cells
- (2015) Kaipeng Huang et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Resveratrol prevents high glucose-induced epithelial–mesenchymal transition in renal tubular epithelial cells by inhibiting NADPH oxidase/ROS/ERK pathway
- (2015) Ting He et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- An Organ System Approach to Explore the Antioxidative, Anti-Inflammatory, and Cytoprotective Actions of Resveratrol
- (2015) Ashim Malhotra et al. Oxidative Medicine and Cellular Longevity
- Gestational diabetes induces alterations of sirtuins in fetal endothelial cells
- (2015) Juan Gui et al. PEDIATRIC RESEARCH
- Meta-analysis: the efficacy and safety of combined treatment with ARB and ACEI on diabetic nephropathy
- (2015) Feifeng Ren et al. RENAL FAILURE
- Redox-fibrosis: Impact of TGFβ1 on ROS generators, mediators and functional consequences
- (2015) Kati Richter et al. Redox Biology
- Endoplasmic Reticulum Stress in the Diabetic Kidney, the Good, the Bad and the Ugly
- (2015) Robyn Cunard Journal of Clinical Medicine
- SIRT2 induces the checkpoint kinase BubR1 to increase lifespan
- (2014) B. J. North et al. EMBO JOURNAL
- Amelioration of streptozotocin-induced diabetic nephropathy by melatonin, quercetin, and resveratrol in rats
- (2014) H Elbe et al. HUMAN & EXPERIMENTAL TOXICOLOGY
- The Aging Kidney: Increased Susceptibility to Nephrotoxicity
- (2014) Xinhui Wang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- AMP-activated protein kinase: a key regulator of energy balance with many roles in human disease
- (2014) D. Grahame Hardie JOURNAL OF INTERNAL MEDICINE
- Effect of Resveratrol Administration on Metabolic Syndrome, Insulin Sensitivity, and Insulin Secretion
- (2014) Miriam Méndez-del Villar et al. Metabolic Syndrome and Related Disorders
- The effect of resveratrol on the expression of AdipoR1 in kidneys of diabetic nephropathy
- (2014) Hongfei Ji et al. MOLECULAR BIOLOGY REPORTS
- Therapeutic potential of resveratrol in diabetic complications: In vitro and in vivo studies
- (2014) Veeresham Ciddi et al. Pharmacological Reports
- Resveratrol Prevention of Diabetic Nephropathy Is Associated with the Suppression of Renal Inflammation and Mesangial Cell Proliferation: Possible Roles of Akt/NF-κB Pathway
- (2014) Feng Xu et al. International Journal of Endocrinology
- In vivo and in vitro metabolism of trans-resveratrol by human gut microbiota
- (2013) Lisa M Bode et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Autophagy and genomic integrity
- (2013) A T Vessoni et al. CELL DEATH AND DIFFERENTIATION
- Sirt1 resists advanced glycation end products-induced expressions of fibronectin and TGF-β1 by activating the Nrf2/ARE pathway in glomerular mesangial cells
- (2013) Kaipeng Huang et al. FREE RADICAL BIOLOGY AND MEDICINE
- Resveratrol Attenuates Early Diabetic Nephropathy by Down-Regulating Glutathione S-Transferases Mu in Diabetic Rats
- (2013) Bei Jiang et al. JOURNAL OF MEDICINAL FOOD
- Adiponectin is expressed and secreted by renal tubular epithelial cells
- (2013) Anna Perri et al. JOURNAL OF NEPHROLOGY
- Potential of resveratrol in the treatment of heart failure
- (2013) Pema Raj et al. LIFE SCIENCES
- Hrd1 participates in the regulation of collagen I synthesis in renal fibrosis
- (2013) Lei Li et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Autophagy in aging and neurodegenerative diseases: implications for pathogenesis and therapy
- (2013) Chen-Chen Tan et al. NEUROBIOLOGY OF AGING
- Resveratrol: Why Is It a Promising Therapy for Chronic Kidney Disease Patients?
- (2013) Juliana F. Saldanha et al. Oxidative Medicine and Cellular Longevity
- Resveratrol Attenuates Diabetic Nephropathy via Modulating Angiogenesis
- (2013) Donghai Wen et al. PLoS One
- At the end of the autophagic road: an emerging understanding of lysosomal functions in autophagy
- (2013) Han-Ming Shen et al. TRENDS IN BIOCHEMICAL SCIENCES
- Sirtuins and renal diseases: relationship with aging and diabetic nephropathy
- (2012) Munehiro Kitada et al. CLINICAL SCIENCE
- High-Dose Resveratrol Supplementation in Obese Men: An Investigator-Initiated, Randomized, Placebo-Controlled Clinical Trial of Substrate Metabolism, Insulin Sensitivity, and Body Composition
- (2012) M. M. Poulsen et al. DIABETES
- Resveratrol prevents renal lipotoxicity and inhibits mesangial cell glucotoxicity in a manner dependent on the AMPK–SIRT1–PGC1α axis in db/db mice
- (2012) M. Y. Kim et al. DIABETOLOGIA
- Drug interaction potential of resveratrol
- (2012) Pascal Detampel et al. DRUG METABOLISM REVIEWS
- High glucose induces renal mesangial cell proliferation and fibronectin expression through JNK/NF-κB/NADPH oxidase/ROS pathway, which is inhibited by resveratrol
- (2012) Lanyu Zhang et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Functional Proteomics Establishes the Interaction of SIRT7 with Chromatin Remodeling Complexes and Expands Its Role in Regulation of RNA Polymerase I Transcription
- (2012) Yuan-Chin Tsai et al. MOLECULAR & CELLULAR PROTEOMICS
- The effect of resveratrol on FoxO1 expression in kidneys of diabetic nephropathy rats
- (2012) Lina Wu et al. MOLECULAR BIOLOGY REPORTS
- Resveratrol supplementation improves glycemic control in type 2 diabetes mellitus
- (2012) Jayesh Kumar Bhatt et al. NUTRITION RESEARCH
- Plasma adiponectin is related to the progression of kidney disease in type 2 diabetes patients
- (2012) Ina Maria Kacso et al. SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION
- Effects of resveratrol on biomarkers of oxidative stress and on the activity of delta aminolevulinic acid dehydratase in liver and kidney of streptozotocin-induced diabetic rats
- (2011) Roberta Schmatz et al. BIOCHIMIE
- Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients
- (2011) Pál Brasnyó et al. BRITISH JOURNAL OF NUTRITION
- Resveratrol Improves Oxidative Stress and Protects Against Diabetic Nephropathy Through Normalization of Mn-SOD Dysfunction in AMPK/SIRT1-Independent Pathway
- (2011) M. Kitada et al. DIABETES
- Protection From Retinopathy and Other Complications in Patients With Type 1 Diabetes of Extreme Duration: The Joslin 50-Year Medalist Study
- (2011) J. K. Sun et al. DIABETES CARE
- Prevention and treatment of diabetes with resveratrol in a non-obese mouse model of type 1 diabetes
- (2011) S.-M. Lee et al. DIABETOLOGIA
- Pyridorin in Type 2 Diabetic Nephropathy
- (2011) E. J. Lewis et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Resveratrol protects against hyperglycemia-induced oxidative damage to mitochondria by activating SIRT1 in rat mesangial cells
- (2011) Ying Xu et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Resveratrol Attenuates Renal Hypertrophy in Early-Stage Diabetes by Activating AMPK
- (2010) Da-Fa Ding et al. AMERICAN JOURNAL OF NEPHROLOGY
- Resveratrol Inhibits Renal Fibrosis in the Obstructed Kidney
- (2010) Jinhua Li et al. AMERICAN JOURNAL OF PATHOLOGY
- Resveratrol suppresses IGF-1 induced human colon cancer cell proliferation and elevates apoptosis via suppression of IGF-1R/Wnt and activation of p53 signaling pathways
- (2010) Jairam Vanamala et al. BMC CANCER
- Resveratrol Modulates Drug- and Carcinogen-Metabolizing Enzymes in a Healthy Volunteer Study
- (2010) H.-H. S. Chow et al. Cancer Prevention Research
- Oxidative Stress in Diabetic Nephropathy
- (2010) N. Kashihara et al. CURRENT MEDICINAL CHEMISTRY
- Diabetic Nephropathy Is Accelerated by Farnesoid X Receptor Deficiency and Inhibited by Farnesoid X Receptor Activation in a Type 1 Diabetes Model
- (2010) X. X. Wang et al. DIABETES
- An Antiinflammatory and Reactive Oxygen Species Suppressive Effects of an Extract ofPolygonum CuspidatumContaining Resveratrol
- (2010) Husam Ghanim et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Chromatin regulation and genome maintenance by mammalian SIRT6
- (2010) Ruth I. Tennen et al. TRENDS IN BIOCHEMICAL SCIENCES
- Regulation Mechanisms and Signaling Pathways of Autophagy
- (2009) Congcong He et al. Annual Review of Genetics
- Abnormal Angiogenesis in Diabetic Nephropathy
- (2009) T. Nakagawa et al. DIABETES
- Modulatory effects of resveratrol on attenuating the key enzymes activities of carbohydrate metabolism in streptozotocin–nicotinamide-induced diabetic rats
- (2008) P. Palsamy et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Change in histone H3 phosphorylation, MAP kinase p38, SIR 2 and p53 expression by resveratrol in preventing streptozotocin induced type I diabetic nephropathy
- (2008) Kulbhushan Tikoo et al. FREE RADICAL RESEARCH
- Adiponectin stimulates phosphorylation of AMP-activated protein kinase α in renal glomeruli
- (2008) Philippe G. Cammisotto et al. JOURNAL OF MOLECULAR HISTOLOGY
- SIRT1 Contributes in Part to Cisplatin Resistance in Cancer Cells by Altering Mitochondrial Metabolism
- (2008) X.-J. Liang et al. MOLECULAR CANCER RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started